obovatol has been researched along with Granulocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huh, TL; Hwang, J; Kim, HS; Lee, S; Lim, GY; Ryoo, ZY | 1 |
1 other study(ies) available for obovatol and Granulocytic Leukemia
Article | Year |
---|---|
Induction of apoptosis by obovatol as a novel therapeutic strategy for acute myeloid leukemia.
Topics: Acute Disease; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Leukemic; Humans; Jurkat Cells; Leukemia, Myeloid; Magnolia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phenyl Ethers; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; U937 Cells | 2014 |